Motoko Tanaka

Summary

Affiliation: Akebono Clinic
Country: Japan

Publications

  1. ncbi Parathyroidectomy markedly reduces oxidative stress in a patient with primary hyperparathyroidism
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Ther Apher Dial 15:38-41. 2011
  2. ncbi Hypercalcaemia is associated with poor mental health in haemodialysis patients: results from Japan DOPPS
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic 5 1 1, Shirafuji, Kumamoto 561 4112, Japan
    Nephrol Dial Transplant 22:1658-64. 2007
  3. ncbi Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients
    M Tanaka
    Department of Nephrology, Akebono Clinic, 5 1 1 Shirafuji, Kumamoto 861 4112, Japan
    Clin Nephrol 64:281-7. 2005
  4. ncbi Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Shirafuji, Kumamoto, Japan
    Nephron Clin Pract 102:c1-7. 2006
  5. ncbi Normalization of reversed bio-intact-PTH(1-84)/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism
    M Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Clin Nephrol 64:69-72. 2005
  6. ncbi Autoinfarction of the parathyroid gland diagnosed by power Doppler ultrasonography in a patient with secondary hyperparathyroidism
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, 5-1-1, Shirafuji, Kumamoto 861-4112, Japan
    Nephrol Dial Transplant 21:1092-5. 2006
  7. ncbi Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, 5 1 1, Shirafuji, Kumamoto 861 4112, Japan
    Ther Apher Dial 9:48-52. 2005
  8. ncbi Infarction of mediastinal parathyroid gland causing spontaneous remission of secondary hyperparathyroidism
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Am J Kidney Dis 44:762-7. 2004
  9. ncbi Clinical usefulness of a new hepatitis C virus RNA extraction method using specific capture probe and magnetic particle in hemodialysis patients
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Ther Apher Dial 8:328-34. 2004
  10. ncbi Two male siblings with hereditary renal hypouricemia and exercise-induced ARF
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Am J Kidney Dis 42:1287-92. 2003

Collaborators

Detail Information

Publications28

  1. ncbi Parathyroidectomy markedly reduces oxidative stress in a patient with primary hyperparathyroidism
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Ther Apher Dial 15:38-41. 2011
    ..These results suggest that parathyroidectomy reduces oxidative stress in patients with primary hyperparathyroidism, which may in part explain the reduced risk for cardiovascular and all-cause mortality after parathyroidectomy...
  2. ncbi Hypercalcaemia is associated with poor mental health in haemodialysis patients: results from Japan DOPPS
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic 5 1 1, Shirafuji, Kumamoto 561 4112, Japan
    Nephrol Dial Transplant 22:1658-64. 2007
    ..Hypercalcaemia and high parathyroid hormone (PTH) levels are aetiological factors of psychological disorders. We examined the association between mineral metabolism abnormalities and mental health in Japanese-DOPPS patients...
  3. ncbi Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients
    M Tanaka
    Department of Nephrology, Akebono Clinic, 5 1 1 Shirafuji, Kumamoto 861 4112, Japan
    Clin Nephrol 64:281-7. 2005
    ..Here we determined the prevalence of Fabry's disease not only in male but also in female HD patients by measuring alpha-Gal A...
  4. ncbi Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Shirafuji, Kumamoto, Japan
    Nephron Clin Pract 102:c1-7. 2006
    ..Although maxacalcitol has been recently developed as a new vitamin D3 and its efficacy is anticipated in SHPT, there are only few reports on the usefulness of combination therapy of intravenous maxacalcitol and selective PEIT...
  5. ncbi Normalization of reversed bio-intact-PTH(1-84)/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism
    M Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Clin Nephrol 64:69-72. 2005
    ..We speculate that the resected parathyroid gland in our patient might have produced a new molecular form of PTH that was less well detected by the conventional intact-PTH assay...
  6. ncbi Autoinfarction of the parathyroid gland diagnosed by power Doppler ultrasonography in a patient with secondary hyperparathyroidism
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, 5-1-1, Shirafuji, Kumamoto 861-4112, Japan
    Nephrol Dial Transplant 21:1092-5. 2006
  7. ncbi Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, 5 1 1, Shirafuji, Kumamoto 861 4112, Japan
    Ther Apher Dial 9:48-52. 2005
    ..Through appropriate selection of patients for PEIT and correct injection of ethanol into the enlarged parathyroid gland, PEIT could accomplish better outcomes based on K/DOQI guidelines...
  8. ncbi Infarction of mediastinal parathyroid gland causing spontaneous remission of secondary hyperparathyroidism
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Am J Kidney Dis 44:762-7. 2004
    ..To the authors' knowledge, this is the first case report of spontaneous mediastinal parathyroid autoinfarction after parathyroidectomy in hemodialysis patients...
  9. ncbi Clinical usefulness of a new hepatitis C virus RNA extraction method using specific capture probe and magnetic particle in hemodialysis patients
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Ther Apher Dial 8:328-34. 2004
    ..Precise identification of HCV-RNA using this specific method is considered to be useful in preventing HCV infection in hemodialysis units...
  10. ncbi Two male siblings with hereditary renal hypouricemia and exercise-induced ARF
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Am J Kidney Dis 42:1287-92. 2003
    ..This is the first report of the 2 male siblings of familial renal hypouricemia complicated with exercise-induced ARF, with definite demonstration of genetic abnormality in the responsible gene (URAT1)...
  11. ncbi Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Ther Apher Dial 15:161-8. 2011
    ..Our data suggest that intravenous calcitriol treatment reduces oxidative stress and strengthens antioxidant defenses by inhibiting albumin oxidation in HD patients with secondary hyperparathyroidism...
  12. ncbi [Usefulness of power Doppler ultrasonography for the diagnosis of autoinfarction of parathyroid gland in secondary hyperparathyroidism]
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto
    Clin Calcium 15:46-9; discussion 49-50. 2005
    ..Here we present a hemodialysis patient with autoinfarction of the left parathyroid gland diagnosed by urgent power Doppler ultrasonography of the neck...
  13. ncbi [Examination of HCV infection in hemodialysis patients with HCV-RNA assay using a magnetic extraction method (AmpliCap GT HCV MONITOR Test Kit v2.0 and AmpliCap GT HCV Specimen Preparation Kit v2.0)]
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Nippon Jinzo Gakkai Shi 45:91-7. 2003
    ..A precise diagnosis using HCV-RNA assay by the magnetic extraction method and precise medication including IFN therapy is desired for improving the long-term prognosis of dialysis patients...
  14. ncbi Effects of raloxifene on bone mineral metabolism in postmenopausal Japanese women on hemodialysis
    Motoko Tanaka
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Ther Apher Dial 15:62-6. 2011
    ..The effects of raloxifene on serum calcium and serum iPTH level suggest it improves bone resorption. Vitamin D and/or calcium salts should be added to raloxifene treatment to avoid secondary hyperparathyroidism...
  15. ncbi Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis
    Kazuko Itoh
    Department of Nephrology, Akebono Clinic, Kumamoto, Japan
    Ther Apher Dial 12:126-32. 2008
    ....
  16. ncbi [Clinical courses of two male siblings on hemodialysis for Fabry disease ]
    Kazuko Itoh
    Department of Nephrology, Akebono Clinic, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
    Nippon Jinzo Gakkai Shi 47:121-7. 2005
    ..Young HD patients with these symptoms will need to be examined for Fabry disease...
  17. ncbi [Effects of fluvastatin on plasma lipid abnormalities in hemodialysis patients with chronic renal failure]
    Motoko Tanaka
    Third Department of Internal Medicine, Kumamoto University School of Medicine, Kumamoto, Japan
    Nippon Jinzo Gakkai Shi 44:402-8. 2002
    ..The possibility that this improvement in the plasma lipid profile of dialysis patients may decrease atherogenic complications requires further investigation, including long-term clinical observations...
  18. ncbi [A hemodialysis patient with secondary hyperparathyroidism in whom primary parathyroid adenoma was resected 27 years previously]
    Kazuko Itoh
    Department of Nephrology, Akebono Clinic, Kumamoto, Aichi, Japan
    Nippon Jinzo Gakkai Shi 45:706-12. 2003
    ..In conclusion, immunohistochemical findings of parathyroid tissue and sequence analysis of MEN1 gene could be useful for the differential diagnosis of primary adenoma and secondary hyperplasia...
  19. ncbi Effect of telmisartan on ambulatory blood pressure monitoring, plasma brain natriuretic peptide, and oxidative status of serum albumin in hemodialysis patients
    Hidetaka Shimada
    Department of Nephrology, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
    Hypertens Res 28:987-94. 2005
    ..A long-term study in a large population is required to determine the influence of telmisartan therapy on cardiovascular mortality and morbidity in HD patients...
  20. ncbi [A case of secondary hyperparathyroidism with an ectopic intrathyroid gland successfully diagnosed and controlled by percutaneous ethanol injection therapy (PEIT)]
    Motoko Tanaka
    NTT Nishinippon Kyushu General Hospital, Japan
    Nippon Jinzo Gakkai Shi 44:409-13. 2002
    ..In this case, it was suggested that tentative PEIT of intrathyroid tumor was a useful method for detecting an ectopic parathyroid gland...
  21. ncbi Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients
    Masafumi Fukagawa
    Division of Nephrology and Kidney Center, Kobe University School of Medicine, Chuo Ku, Kobe, Japan
    Nephrol Dial Transplant 23:328-35. 2008
    ..In this study, we examined the efficacy and safety of cinacalcet in Japanese patients on maintenance haemodialysis...
  22. ncbi Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
    Hirotaka Komaba
    Division of Nephrology and Kidney Center, Kobe University School of Medicine, Kobe
    Intern Med 47:989-94. 2008
    ..Harmonizing these therapeutic modalities, we should expect more effective management of CKD-MBD, leading to the improvement of morbidity and mortality in this patient population...
  23. ncbi [Basic and clinical aspects of calcimimetics. Treatment of secondary hyperparathyroidism in dialysis patients with calcimimetics]
    Motoko Tanaka
    Akebono Clinic, Department of Nephrology, Japan
    Clin Calcium 18:89-93. 2008
    ..Recently, calcimimetics has been expected as a new strategy for SHPT in Japan. In this article, we reviewed the usefulness of calcimimetics for SHPT of dialysis patients...
  24. ncbi Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism?
    Yoshihiro Tominaga
    Department of Surgery, Renal Center, Nagoya Second Red Cross Hospital, Nagoya, Japan
    Ther Apher Dial 10:198-204. 2006
    ..We conclude that the glandular volume of the largest parathyroid gland estimated by US can be a useful factor to predict the OCT response in patients with moderate or severe renal HPT...
  25. ncbi [Bone and bone related biochemical examinations. Hormone and hormone related substances. Parathyroid hormone]
    Motoko Tanaka
    Akebono Clinic, Department of Nephrology
    Clin Calcium 16:927-34. 2006
    ..Recently, a new molecular form of PTH has been reported, which cannot be detected by these newer PTH assays...
  26. ncbi Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone
    Masaaki Shimotori
    Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
    Hum Mutat 29:331. 2008
    ..Although ASSC therapy is useful only for misfolding mutants and therefore not applicable to all cases, it may be useful for treating many Japanese patients with Fabry disease...
  27. ncbi Serum pro-hepcidin as an indicator of iron status in dialysis patients
    Daisuke Tsuchihashi
    Division of Nephrology and Dialysis Center, Kobe University School of Medicine, Kobe, Japan
    Ther Apher Dial 12:226-31. 2008
    ..9] ng/mL; not significant). Pro-hepcidin could serve as a marker for functional iron deficiency and disordered iron utilization in HD. Underlying mechanisms and improvements in measurement techniques will require additional investigation...
  28. ncbi The kidney and bone metabolism: Nephrologists' point of view
    Masafumi Fukagawa
    Division of Nephrology and Dialysis Center, Kobe University School of Medicine, 7 5 2 Kusunoki cho, Chuo Ku, Kobe, 650 0017, Japan
    J Bone Miner Metab 24:434-8. 2006
    ..In order to maintain the bone quality in patients with CKD, bone changes due to aging, menopause, and malnutrition need to be considered by nephrolgists and non-nephrologists in collaboration...